Informational paper: Drug-associated gingival enlargement

Journal of Periodontology

Volumn 75, Issue 10, 2004, Pages 1424-1431

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

AGON; AMLODIPINE BESYLATE; AMLODIPINE PLUS BENAZEPRIL; ANTICONVULSIVE AGENT; ATENOLOL PLUS NIFEDIPINE; AZITHROMYCIN; CALCIUM CHANNEL BLOCKING AGENT; CARBAMAZEPINE; COVERA; CYCLOSPORIN A; DILTIAMAX; DILTIAZEM; ENALAPRIL MALEATE PLUS FELODIPINE; FELODIPINE; FELODUR; GABAPENTIN; IMMUNOSUPPRESSIVE AGENT; ISRADIPINE; LAMOTRIGINE; METRONIDAZOLE; NIFECARD; NIFEDIPINE; NYSTATIN; PHENOBARBITAL; PHENYTOIN; SULTIAME; TACROLIMUS; TOPIRAMATE; TRANDOLAPRIL PLUS VERAPAMIL; UNCLASSIFIED DRUG; VALPROIC ACID; VERAPAMIL; VIGABATRIN;

CLINICAL FEATURE; DRUG INDUCED DISEASE; DRUG WITHDRAWAL; GINGIVA HYPERTROPHY; HISTOPATHOLOGY; HUMAN; OUTCOMES RESEARCH; PATHOGENESIS; PREVALENCE; PREVENTIVE DENTISTRY; RECURRENCE RISK; REVIEW; RISK FACTOR; TOOTH PLAQUE;

EID: 8744279143     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2004.75.10.1424     Document Type: Review

References (76)

1. Rees TD, Levine RA. Systemic drugs as a risk factor for periodontal disease initiation and progression. Compend Contin Educ Dent 1995;16:20-42.
2. Lewis IK, Hanlon JT, Schmader KE, et al. Use of medications with potential oral adverse drug interactions in community-dwelling elderly. Spec Care Dentist 1993;13: 171-176.
3. Marshall RI, Bartold PM. A clinical review of drug-induced gingival overgrowth. Aust Dent J 1999;44:219-232.
4. Dongari AI, Langlais RP, McDonnell HT. Drug-induced gingival overgrowth. Oral Surg Oral Med Oral Pathol 1993;76:543-548.
5. Seymour R, Heasman P. Drugs, Diseases and the Periodontium Oxford: Oxford University Press; 1992.
6. Dahlof G, Preber H, Eliasson S, et al. Periodontal condition of epileptic adults treated long-term with phenytoin or carbamazepine. Epilepsia 1993;34:960-964.
7. Gregoriou A, Schneider P, Shaw P. Phenobarbital-induced gingival overgrowth? Report of two cases and complications in management. ASDC J Dent Child 1996;63: 408-413.
8. Katz J, Givol N, Chaushu G, Taicher S, Shemer J. Vigabatrin-induced gingival overgrowth. J Clin Periodontol 1997;24:180-182.
9. Hallmon WW, Rossmann JA. The role of drugs in the pathogenesis of gingival overgrowth. A collective review of current concepts. Periodontol 2000 1999;21:176-196.
10. Proceedings of the Second International Congress on Cyclosporine. Washington, DC: Grune and Stratton; 1988:1-25.
11. Hassell TM, Hefti AF. Drug-induced gingival overgrowth: Old problem, new problem. Crit Rev Oral Biol Med 1991;2:103-137.
12. Rateitschak-Pluss E, Hefti A, Lortscher R, Thiel G. Initial observation that cyclosporin-A induces gingival enlargement in man. J Clin Periodontol 1983;10:237-246.
13. Myers BD, Newton L. Cyclosporine-induced chronic nephropathy: An obliterative microvascular renal injury. J Am Soc Nephrol 1991 Aug;2(2 Suppl. 1):S45-S52.
14. Platt JL, Ferguson RM, Sibley RK, Gajl-Peczalska KJ, Michael AF. Renal interstitial cell populations in cyclosporine nephrotoxicity: Identification using monoclonal antibodies. Transplantation 1983;36:343-346.
15. Billingham ME. Diagnosis of acute cardiac rejection by endomyocardial biopsy. Bibl Cardiol 1988;43:83-102.
16. Calne RY, Thiru S, McMaster P, et al. Cyclosporine A in patients receiving renal allografts from cadaver donors. Lancet 1978;2:1323-1327.
17. Casetta I, Granieri E, Desidera M, et al. Phenytoin-induced gingival overgrowth: A community-based cross-sectional study in Ferrara, Italy. Neuroepidemiology 1997;16:296-303.
18. Barak S, Engelberg I, Hiss Z. Gingival hyperplasia caused by nifedipine: Histopathological findings. J Periodontol 1987;58:639-642.
19. Fattore L, Stablein M, Bredfelt G, et al. Gingival hyperplasia: A side effect of nifedipine and diltiazem. Spec Care Dent 1991;11:107-109.
20. Ellis JS, Seymour RA, Steele JG, Robertson P, Butler TJ, Thomason JM. Prevalence of gingival overgrowth induced by calcium channel blockers: A community-based study. J Periodontol 1999;70:63-67.
21. Boltchi FE, Rees TD, Iacopino AM. Cyclosporine A-induced gingival overgrowth: A comprehensive review. Quintessence Int 1999;30:775-783.
22. Kilpatrick NM, Weintraub RG, Lucas JO, Shipp A, Byrt T, Wilkinson JL. Gingival overgrowth in pediatric heart and heart-lung transplant recipients. J Heart Lung Transplant 1997;16:1231-1237.
23. Ciancio S, Bartz N, Lauciello F. Cyclosporine-induced gingival hyperplasia and chlorhexidine: A case report. Int J Periodontics Restorative Dent 1991;11:241-245.
24. Fu E, Nieh S, Hsiao CT, Hsieh YD, Wikesjö UM, Shen EC. Nifedipine-induced gingival overgrowth in rats: Brief review and experimental study. J Periodontol 1998;69: 765-771.
25. Meller AT, Rumjanek VM, Sansone C, Allodi S. Oral mucosa alterations induced by cyclosporin in mice: Morphological features. J Periodontal Res 2002;37: 412-415.
26. Andriani F, Margulis A, Lin N, Griffey S, Garlick JA. Analysis of microenvironmental factors contributing to basement membrane assembly and normalized epidermal phenotype. J Invest Dermatol 2003;120:923-931.
27. Nakou M, Kamma JJ, Andronikaki A, Mitsis F. Sub-gingival microflora associated with nifedipine-induced gingival overgrowth. J Periodontol 1998;69:664-669.
28. Armitage GC. Development of a classification system for periodontal diseases and conditions. Ann Periodontol 1999;4:1-6.
29. Fu E, Nieh S, Wikesjö UM. The effect of plaque retention on cyclosporine-induced gingival overgrowth in rats. J Periodontol 1997;68:92-98.
30. Thomas DW, Newcombe RG, Osborne GR. Risk factors in the development of cyclosporine-induced gingival overgrowth. Transplantation 2000;69:522-526.
31. Varga E, Lennon MA, Mair LH. Pre-transplant gingival hyperplasia predicts severe cyclosporin-induced gingival overgrowth in renal transplant patients. J Clin Periodontol 1998;25:225-230.
32. Thomason J, Kelly P, Seymour R. The distribution of gingival overgrowth in organ transplant patients. J Clin Periodontol 1996;23:367-371.
33. Penarrocha-Diago M, Bagan-Sebastian J, Vera-Sempere F. Diphenylhydantoin-induced gingival overgrowth in man: A clinico-pathological study. J Periodontol 1990;61:571-574.
34. Nery E, Edson R, Lee K, et al. Prevalence of nifedipine-induced gingival hyperplasia. J Periodontol 1995;66: 572-578.
35. Thomason J, Seymour R, Ellis J, et al. Determinants of gingival overgrowth severity in organ transplant recipients: An examination of the role of the HLA phenotype. J Clin Periodontol 1996;23:628-634.
36. Cebeci I, Kantarci A, Firatli E, et al. Evaluation of the frequency of HLA determinants in patients with gingival overgrowth induced by cyclosporine A. J Clin Periodontol 1996;23:737-742.
37. Kamali F, McLaughlin WS, Ball DE, Seymour RA. The effect of multiple anticonvulsant therapy on the expression of phenytoin-induced gingival overgrowth. J Clin Periodontol 1999;26:802-805.
38. Wilson RF, Morel A, Smith D, et al. Contribution of individual drugs to gingival overgrowth in adult and juvenile renal transplant patients treated with multiple therapy. J Clin Periodontol 1998;25:457-464.
39. Thomason JM, Ellis JS, Kelly PJ, Seymour RA. Nifedipine pharmacological variables as risk factors for gingival overgrowth in organ-transplant patients. Clin Oral Invest 1997;1:35-39.
40. James JA, Marley JJ, Jamal S, et al. The calcium channel blocker used with cyclosporin has an effect on gingival overgrowth. J Clin Periodontol 2000;27:109-115.
41. Morisaki I, Fukui N, Fujimori Y, Murakami J, Daikoku H, Amano A. Effects of combined oral treatments with cyclosporine A and nifedipine or diltiazem on drug-induced gingival overgrowth in rats. J Periodontol 2000; 71:438-443.
42. Meraw SJ, Sheridan PJ. Medically induced gingival hyperplasia. Mayo Clin Proc 1998;73:1196-1199.
43. Khocht A, Schneider LC. Periodontal management of gingival overgrowth in the heart transplant patient: A case report. J Periodontol 1997;68:1140-1146.
44. Payne VM. Re: Periodontal management of gingival overgrowth in the heart transplant patient: A case report (1997;68:1140-1146). J Periodontol 1998;69:1314-1315.
45. Mariani G, Calastrini C, Carinci F, et al. Ultrastructural features of CsA-induced gingival hyperplasia. J Periodontol 1993;64:1092-1097.
46. Wysocki GP, Gretzinger HA, Laupacis A, Ulan RA, Stiller CR. Fibrous hyperplasia of the gingiva: A side effect of cyclosporin-A therapy. Oral Surg Oral Med Oral Pathol 1983;55:274-278.
47. Rostock MH, Fryt HR, Turner JE. Severe gingival overgrowth associated with cyclosporine therapy. J Periodontol 1986;57:294-299.
48. Santi E, Bral M. Effect of treatment on cyclosporine-and nifedipine-induced gingival enlargement: Clinical and histologic results. Int J Periodontics Restorative Dent 1998;18:80-85.
49. Hassell TM, Page RC, Narayanan AS, Cooper CG. Diphenylhydantoin (Dilantin) gingival hyperplasia: Drug-induced abnormality of connective tissue. Proc Natl Acad Sci (USA) 1976;73:2909-2912.
50. Montebugnoli L, Bernardi F. Cyclosporin A effects on extraoral connective tissue in heart transplanted patients. J Int Acad Periodontol 1999;1:91-94.
51. Sinha-Morton R, Dongari-Bagtzoglou AI. Regulation of gingival fibroblast interleukin-6 secretion by cyclosporine A. J Periodontol 1999;70:1464-1471.
52. Dongari-Bagtzoglou A, Ebersole JL. Increased presence of interleukin-6 (IL-6) and IL-8 secreting fibroblast subpopulations in adult periodontitis. J Periodontol 1998; 69:899-910.
53. Hassell TM, Buchanan J, Cuchens M, et al. Fluorescence activated vital cell sorting of human fibroblast subpopulations that bind CsA. J Dent Res 1988;67:273-276.
54. Mariotti A, Hassell T, Jacobs D, Manning CJ, Hefti AF. Cyclosporin A and hydroxycyclosporine (M-17) affect the secretory phenotype of human gingival fibroblasts. J Oral Pathol Med 1998;27:260-266.
55. Johnson RB, Zebrowski EJ, Dai X. Synergistic enhancement of collagenous protein synthesis by human gingival fibroblasts exposed to nifedipine and interleukin-1-beta in vitro. J Oral Pathol Med 2000;29:8-12.
56. Williamson MS, Miller EK, Plemons J, Rees T, Iacopino AM. Cyclosporine A upregulates interleukin-6 gene expression in human gingiva: Possible mechanism for gingival overgrowth. J periodontol 1994;65:895-903.
57. Fries KM, Felch M, Phipps R. Interleukin-6 is an autocrine growth factor for murine lung fibroblast subsets. Am J Respir Cell Mol Biol 1994; 11:552-560.
58. Duncan MR, Berman B. Stimulation of collagen and glycosaminoglycan production in cultured human adult dermal fibroblasts by recombinant human interleukin-6. J Invest Dermatol 1991;97:686-689.
59. Myrillas TT, Linden GJ, Marley JJ, Irwin CR. Cyclosporin A regulates interleukin-1 beta and interleukin-6 expression in gingiva: Implications for gingival overgrowth. J Periodontol 1999;70:294-300.
60. Hassell TM. Evidence for production of an inactive collagenase by fibroblasts from phenytoin-enlarged human gingiva. J Oral Pathol 1982;11:310-317.
61. Bolzani G, Della Coletta R, Martelli Junior H, Martelli Junior H, Graner E. Cyclosporin A inhibits production and activity of matrix metalloproteinases by gingival fibroblasts. J Periodontal Res 2000;35:51-58.
62. Kataoka M, Shimizu Y, Kunikiyo K, et al. Cyclosporin A decreases the degradation of type I collagen in rat gingival overgrowth. J Cell Physiol 2000;182:351-358.
63. Hall EE. Prevention and treatment considerations in patients with drug-induced gingival enlargement. Curr Opin Periodontol 1997;4:59-63.
64. Boraz RA. A dental protocol for the pediatric cardiac transplant patient. ASDC J Dent Child 1986;53:382-385.
65. Pilatti GL, Sampaio JE. The influence of chlorhexidine on the severity of cyclosporin A-induced gingival overgrowth. J Periodontol 1997;68:900-904. Erratum in: J Periodontol 1998; 69:102.
66. Westbrook P, Bednarczyk EM, Carlson M, Sheehan H, Bissada NF. Regression of nifedipine-induced gingival hyperplasia following switch to a same class calcium channel blocker, isradipine. J Periodontol 1997;68:645-650.
67. James JA, Boomer S, Maxwell AP, et al. Reduction in gingival overgrowth associated with conversion from cyclosporin A to tacrolimus. J Clin Periodontol 2000;27: 144-148.
68. Somacarrera ML, Lucas M, Scully C, Barrios C. Effectiveness of periodontal treatments on cyclosporine-induced gingival overgrowth in transplant patients. Br Dent J 1997;183:89-94.
69. Gomez E, Sanchez-Nunez M, Sanchez JE, et al. Treatment of cyclosporin-induced gingival hyperplasia with azithromycin. Nephrol Dial Transplant 1997;12:2694-2697.
70. Strachan D, Burton I, Pearson GJ. Is oral azithromycin effective for the treatment of cyclosporine-induced gingival hyperplasia in cardiac transplant recipients? J Clin Pharm Ther 2003;28:329-338.
71. Mesa FL, Osuna A, Aneiros J, et al. Antibiotic treatment of incipient drug-induced gingival overgrowth in adult renal transplant patients. J Periodontal Res 2003; 38:141-146.
72. Ilgenli T, Atilla G, Baylas H. Effectiveness of periodontal therapy in patients with drug-induced gingival overgrowth. Long-term results. J Periodontol 1999;70:967-972.
73. Hildebrand HC, Hakkinen L, Wiebe CB, Larjava HS. Characterization of organotypic keratinocyte cultures on de-epithelialized bovine tongue mucosa. Histol Histopathol 2002;17:151-163.
74. Cotrim P, Martelli-Junior H, Graner E, Sauk JJ, Coletta RD. Cyclosporin A induces proliferation in human gingival fibroblasts via induction of transforming growth factor-beta 1. J Periodontol 2003;74:1625-1633.
75. Gnoatto N, Lotufo RF, Toffoletto O, Marquezini MV. Gene expression of extracellular matrix proteoglycans in human cyclosporin-induced gingival overgrowth. J Periodontol 2003;74:1747-1753.
76. Bolcato-Bellemin AL, Elkaim R, Tenenbaum H. Expression of RNAs encoding for alpha and beta integrin subunits in periodontitis and in cyclosporin A gingival overgrowth. J Clin Periodontol 2003;30:937-943.